The Procurement of Active Pharmaceutical Ingredient Physostigmine Free Base
Details
- Buyer
- Ministry of Defence
- Topic
- Other nervous system medicinal products
- Published
- 13 May 2022
- Source
- uk:find_a_tender
Tender description
The purpose of this Prior Information Notice (PIN) is to: • Share information on Dstl’s current thinking regarding a requirement to supply a quantity of Physostigmine Free Base over the next 5-7 years, with the potential for a long term supply; • Obtain views & feedback on this from the market, including responses to the questions detailed in this document; • Provide the ability for the market to highlight areas of opportunity/innovation that Dstl are not currently aware of; • Use the feedback & information to inform & support the development of the future Business Case(s) & Procurement Strategy. This PIN questionnaire is not a request for a full proposal or bid nor should it be taken to be a call for competition, it is purely to obtain information from early engagement with the market. In supporting a potential wider MOD requirement, Dstl is currently exploring the availability & capacity within the market to supply a quantity of the Active Pharmaceutical Ingredient (API), Physostigmine Free Base (also known as eserine; chemical name 1,2,3,3aβ,8,8aβ-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-yl-methylcarbamate; chemical formula C15H21N3O2; molecular weight 275,36 g/mol). Under consideration is the development, process validation, manufacture & supply of this API with an outline indicative quantity of approx.15kg to 20kg per annum. The PIN questionnaire is seeking to identify where possible that the ultimate requirement is market facing/realistic/deliverable & the potential cost of the approach. Any information shared in response to the questionnaire, will be provided on the basis that it gives Dstl/UK MOD with free & unrestricted use of it in consideration of our requirement. It will not be shared outside of Dstl/UK MOD. Dstl is also interested in responses that propose different approaches or areas of efficiency that subject matter experts consider could be deemed in scope. Dstl gives no guarantee whatsoever that such proposals will be taken forward. Lot 1: Prior Information Notice (PIN) Questionnaire – Procurement of Active Pharmaceutical Ingredient – Physostigmine Free Base Purpose: The purpose of this Prior Information Notice (PIN) questionnaire is to: • Share information on Dstl’s current thinking regarding a requirement to supply a quantity of Physostigmine Free Base over the next 5-7 years, with the potential for a long term supply; • Obtain views and feedback on this from the market, including responses to the questions detailed in this document; • Provide the ability for the market to highlight areas of opportunity/innovation that Dstl are not currently aware of; • Use the feedback and information to inform and support the development of the future Business Case(s) and Procurement Strategy. This PIN questionnaire is not a request for a full proposal or bid nor should it be taken to be a call for competition, it is purely to obtain information from early engagement with the market. Background: In supporting a potential wider MOD requirement, Dstl is currently exploring the availability and capacity within the market to supply a quantity of the Active Pharmaceutical Ingredient (API), Physostigmine Free Base (also known as eserine; chemical name 1,2,3,3aβ,8,8aβ-hexahydro-1,3a,8-trimethylpyrrolo[2,3-b] indol-5-yl-methylcarbamate; chemical formula C15H21N3O2; molecular weight 275,36 g/mol). Under consideration is the development, process validation, manufacture and supply of this API with an outline indicative quantity of approx. 15kg to 20kg per annum The Purpose of this PIN questionnaire is to assist in preparing a Business Case and Procurement Strategy for this future requirement. The PIN questionnaire is seeking feedback and advice from the market to help understand and to identify where possible that the ultimate requirement is market facing/realistic/deliverable and the potential cost of the approach; Please note that this is not a request for proposals or tenders at this stage. Any information shared with us in responses to the questionnaire, will be provided on the basis that it gives Dstl/UK MOD with the right to free and unrestricted use of it in consideration of our requirement. It will not, however, be shared outside of Dstl/UK MOD. Miscellaneous: Dstl is also interested in receiving responses that propose different approaches or areas of efficiency that subject matter experts in this field consider could be deemed to be in scope. Dstl gives no guarantee whatsoever that such proposals will be taken forward.
Timeline
- Completed: Pre-tender published13 May 2022Current notice
About the buyer
Ministry of Defence is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33661700 · Other nervous system medicinal products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@ministry-of-defence.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@ministry-of-defence.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@ministry-of-defence.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@ministry-of-defence.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@ministry-of-defence.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@ministry-of-defence.gov |
Related topics
Topics related to The Procurement of Active Pharmaceutical Ingredient Physostigmine Free Base, ranked by notice volume.
- 11,175£1.0tn
- 26,969£1.7tn
Related buyers
Buyers similar to Ministry of Defence.
- 750£1.3bn
- 692£133.2bn
- 641£160.0bn
- 458£8.1bn
- 338£7.4bn
- 326£1.3bn
- 280£1.1bn
- 263£902.6m
- 228£550.1m
- 184£222.3bn
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
